Over the past year there were no insider purchases at Bioventus Inc.. Two insiders sold roughly $313,000 instead.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters. 157 investment managers listed BVS in their latest 13F filings (Q2 2026); more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | McMurry-Heath Michelle | Director | Sell | 12,000 | $8.79 | $105K | SEC |
| Dec 8, 2025 | NOHRA GUY P | Director | Sell | 10,000 | $7.57 | $76K | SEC |
| Nov 10, 2025 | McMurry-Heath Michelle | Director | Sell | 17,701 | $7.42 | $131K | SEC |
| Apr 15, 2025 | Singleton Mark Leonard | CFO | Sell | 3,875 | $7.57 | $29K | SEC |
| Apr 15, 2025 | D'Adamio Anthony | Executive Officer | Sell | 2,958 | $7.57 | $22K | SEC |
| Apr 15, 2025 | CHURCH KATRINA J | Executive Officer | Sell | 1,283 | $7.57 | $10K | SEC |
| Mar 25, 2025 | Singleton Mark Leonard | CFO | Sell | 5,479 | $9.79 | $54K | SEC |
| Mar 18, 2025 | CHURCH KATRINA J | Executive Officer | Sell | 1,018 | $9.75 | $10K | SEC |
| Mar 18, 2025 | D'Adamio Anthony | Executive Officer | Sell | 2,615 | $9.75 | $25K | SEC |
| Feb 20, 2025 | Singleton Mark Leonard | CFO | Sell | 6,498 | $10.19 | $66K | SEC |
| Feb 20, 2025 | D'Adamio Anthony | Executive Officer | Sell | 4,380 | $10.19 | $45K | SEC |
| Feb 20, 2025 | CHURCH KATRINA J | Executive Officer | Sell | 1,537 | $10.19 | $16K | SEC |
| Jan 14, 2025 | Claypoole Robert E | CEO | Sell | 28,786 | $9.10 | $262K | SEC |
| Dec 26, 2024 | Singleton Mark Leonard | CFO | Sell | 10,733 | $10.53 | $113K | SEC |
| Dec 26, 2024 | D'Adamio Anthony | Executive Officer | Sell | 5,848 | $10.53 | $62K | SEC |
In the last 12 months Bioventus Inc. insiders made open-market purchases worth about $0 and sales worth about $313,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in BVS was filed on 2026-03-13.
157 investment managers reported holding BVS in SEC Form 13F filings for Q2 2026.
No congressional trades in BVS were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).